Fecal immunochemical testing (FIT) was more accurate than blood-based testing for detecting advanced precancerous colorectal ...

Lowering the fecal immunochemical test (FIT) positive threshold yields levels of sensitivity and specificity that are comparable to those reported for multitarget stool RNA (mt-sRNA) testing ...

A revolutionary test known ... from traditional testing methods. Unlike older tests, such as the fecal occult blood test (FOBT), which lacked sensitivity and accuracy, FIT offers a range of ...

(HealthDay)—Administration of a single dose of oral aspirin prior to fecal immunochemical testing does not increase test sensitivity for detecting advanced colorectal neoplasms, according to a ...

Of the 9989 participants who could be evaluated, 65 (0.7%) had colorectal cancer and 757 (7.6%) had advanced precancerous lesions (advanced adenomas or sessile serrated polyps measuring ≥1 cm in ...

The primary outcomes were sensitivity ... testing was used to control the type I error: sensitivity for colorectal cancer had to be greater with the next-generation multitarget stool test than ...

The basic FIT ... the Shield test, tends to be better at identifying cancer itself. So, if that test is positive, it's more commonly in patients who may already have cancer. The sensitivity ...